The Effect of Antidepressants on Human Mesenchymal Stem Cell Osteogenesis and Adipogenesis
- Research Opportunity
- PhD, Masters by Research, Honours
- Number of Honour Places Available
- Medicine and Radiology
- Western Health
|Professor Gustavo Duquefirstname.lastname@example.org||03 8395 8121||Personal web page|
Previous studies have shown a link between bone mass density and depression/antidepressant use. For example, analyses of clinical data have suggested an association between a low bone mass density and/or fractures, and symptoms of depression. In addition, low bone mass density and/or increased tendency to fracture appear to correlate with antidepressant use, particularly among specific antidepressant drug classes. There may be a molecular basis for these clinical data; however, the causative factor(s) have yet to be conclusively established. On the other hand, conflicting studies
have shown no association between symptoms of depression or antidepressant use and bone mass density.
Despite these clinical data, there has been limited biochemical data to substantiate these claims. One way antidepressants may be affecting bone mass is through altering the ability of stem cells to differentiate into new, bone- building osteoblasts. Further, evidence of the role (if any) of antidepressants in the differentiation of stem cells into adipocytes is lacking in literature. Thus, we seek to discover whether antidepressants have any effect on the differentiation ability of human mesenchymal stem cells into osteoblasts and adipocytes within our in vitro cell systems.
School Research Themes
PhD, Masters by Research, Honours
Students who are interested in joining this project will need to consider their elegibility as well as other requirements before contacting the supervisor of this research
For further information about this research, please contact a supervisor.
Research NodeWestern Health
MDHS Research library
Explore by researcher, school, project or topic.